MINS, AKI and Pulmonary Pathology in Patients Undergoing Acute Abdominal Surgery
Myocardial Injury After Non-cardiac Surgery (MINS), Acute Kidney Injury (AKI) and Pulmonary Pathology in Patients Undergoing Acute Abdominal Surgery
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The main issues are:
- To investigate if coronary calcification predisposes the development of myocardial injury and causes an increased mortality rate.
- To evaluate the predictive value of NT-pro-BNP in relation to the development of MINS and the mortality rate.
- To evaluate the predictive value of different biomarkers of AKI in relation to which patients develop AKI.
- To examine the proteins, exosomes and single cell RNA during acute kidney injury in order to describe the molecular processes in the kidney during AKI.
- To examine whether a chest CT scan without contrast enhancement will change treatment decisions in the acute gastrointestinal patient compared with a chest x-ray.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hillerød, Denmark, 3400
- Nordsjaellands Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults (≥18 years).
- Patients included in the AHA regimen undergoing CT on suspicion acute high-risk abdominal disorder e.g.g bowel obstruction GI perforation or ischemia, and need of emergency abdominal surgery, either laparoscopic surgery or laparotomy.
- Able to speak Danish. In case Danish was not spoken an interpreter was used to obtain the informed consent.
- Able to give informed consent.
Exclusion Criteria:
- Patients who cannot give informed consent to participate in the study 15 minutes after receiving verbal information regarding the study.
- Known chronic kidney disease requiring dialysis at the time of admission (only exclusion criteria for the part of the study relating to AKI).
- Patients included in the AHA regimen, but conservative treatment is chosen (only exclusion criteria for the part of the study relating to MINS and AKI).
- Patients not resident in Denmark.
- Patients not able to give informed consent.
- Patient not able to speak Danish and not enough time to obtain an interpreter.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: All patients
All patients undergo chest CT without contrast enhancement and chest X-ray.
Blood and urine sampling from patients subsequently undergoing emergency laparoscopy or laparotomy.
Otherwise standard care
|
Chest CT without contrast enhancement and chest X-ray as supplement to diagnostic abdominal CT
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients with myocardial injury af non-cardiac surgery
Time Frame: 30 days
|
Troponin-I above specified level and dynamic changes
|
30 days
|
|
Mortality rate
Time Frame: 30 days
|
Postoperative mortality
|
30 days
|
|
Mortality rate
Time Frame: 90 days
|
Postoperative mortality
|
90 days
|
|
Mortality rate
Time Frame: 1 year
|
Postoperative mortality
|
1 year
|
|
Acute kidney Injury
Time Frame: 30 days
|
According to KIDGO criteria
|
30 days
|
|
Proportion of patients with pulmonary pathology
Time Frame: 1 day
|
Findings (including incidental) on a chest x-ray and chest CT scan without contrast enhancement
|
1 day
|
|
Proportion of patients with pulmonary complications
Time Frame: 30 days
|
Postoperative complications
|
30 days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Chair: Claus A Bertelsen, PhD, Nordsjaellands Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Kidney Diseases
- Urologic Diseases
- Pain
- Neurologic Manifestations
- Signs and Symptoms, Digestive
- Renal Insufficiency
- Abdominal Pain
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Wounds and Injuries
- Acute Kidney Injury
- Abdomen, Acute
Other Study ID Numbers
Other Study ID Numbers
- AHA (Other Identifier: American Heart Association)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.